SIR Publishes Practice Guidance for PAE

June 2, 2026—The Society of Interventional Radiology (SIR) published a new practice guidance on prostate artery embolization (PAE) for the treatment of benign prostatic hyperplasia (BPH).

RADIANT Pivotal Trial Approved for Arsenal’s NeoCast Liquid Embolic for Chronic Subdural Hematoma

May 26, 2026—Arsenal Medical announced that the FDA granted investigational device exemption approval for the RADIANT pivotal trial.

FDA Approves Reduced Shake Time for Medtronic’s Onyx 18 and Onyx 34

May 19, 2026—Medtronic Neurovascular announced that its Onyx Liquid Embolic System (LES), Onyx 18 and Onyx 34, received FDA approval for a shake time of at least 1 minute with the same product performance.

Medtronic’s Concerto Versa Detachable Coil Used in First Commercial Procedures

May 14, 2026—Medtronic announced the first procedures were performed using the Concerto Versa coil, indicated for arterial and venous embolization in the peripheral vasculature to help control bleeding or treat vascular disease.

SIR Position Statement Supports Genicular Artery Embolization to Treat Symptomatic Knee Osteoarthritis

May 13, 2026—The Society of Interventional Radiology (SIR) announced the publication of a position statement that provides evidence-based support for the use of genicular artery embolization (GAE) as a minimally invasive treatment option for patients with symptomatic knee osteoarthritis (KOA) who have failed conservative therapy and are not candidates for, or wish to delay, total knee arthroplasty.

Microbot Liberty Endovascular Robotic System Launched With Full Market Release in the United States

April 13, 2026—Microbot Medical Inc. announced that it has executed a limited market release of the Liberty robotic system for peripheral endovascular procedures.

CUC America Forms Collaborations With Drs. Okuno and Ahmed to Advance MSK Embolization and Build a Scalable OBL Platform

April 11, 2026—CUC America, a provider of advanced vascular and interventional care, announced strategic collaborations with Yuji Okuno, MD, and Osman Ahmed, MD, to accelerate the adoption of musculoskeletal (MSK) embolization and expand access to innovative, minimally invasive therapies across the United States.

ALPHA Registry Studies Okami LOBO Vascular Occlusion System

April 8, 2026—Okami Medical announced the enrollment of the first patient in the ALPHA registry, a prospective, multicenter registry evaluating the safety and effectiveness of the company’s LOBO vascular occlusion system for patients with a variety of peripheral vascular conditions, including arterial hemorrhage and pulmonary arteriovenous malformation.

Embolization, Inc.’s Polymer-Based NED Coil Evaluated in Limited-Market Release 

April 7, 2026—Embolization, Inc. announced findings from the limited-market release of the company’s nitinol enhanced device (NED), which is a radiopaque, polymer-based embolic coil.

Feasibility Trial Begins for Fluidx’s Ultra Embolic Gel in Treatment of Hypervascular Tumors and Blood Vessels

April 2, 2026—Fluidx Medical Technology, Inc. announced that the first patient has been treated with the company’s Ultra embolic gel in a feasibility trial of the device conducted in New Zealand.

Shape Memory Medical Initiates First-in-Human FLAGSHIP Study of False Lumen Embolization System

April 1, 2026—Shape Memory Medical has announced the first patient enrollments in the FLAGSHIP study, a prospective single-arm open-label first-in-human trial evaluating its investigational False Lumen Embolization (FLE) System for treatment of aortic dissection.